CAC
FLAC

Cowen and Company’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

Cowen and Company’s Portfolio FLAC Stock Details FLAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24,397
Closed -$243K – 791
2021
Q1 		$243K Buy
+24,397
New +$249K 0.02% 251

Other funds holding FLAC

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
DCM
DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $5.1B AUM 39.13% 1-Year Est. Return
ESCM
Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return

Cowen and Company's FLAC Position: Q2 2021 in Review

Cowen and Company sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q2 2021, closing a stake of 24,397 shares — an estimated $243K sold.

Cowen and Company first reported a position in FLAC in Q1 2021 and held it in 1 quarter. The position peaked at $243K in Q1 2021. 41 funds tracked by Wall St. Rank hold FLAC as of Q2 2021.

  • Cowen and Company reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • Cowen and Company sold 24,397 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q2 2021, an estimated $243K.
  • Cowen and Company first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 1 quarter.
  • Cowen and Company's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $243K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q2 2021.

Based on Cowen and Company's 13F filing for Q2 2021, filed 13 Aug 2021.